BrainChip (ASX:BRN) granted eighth US patent

• BrainChip Holdings (BRN) is granted its eight US patent
• The patent, entitled “Event based Classification of Features in a Reconfigurable and Temporally Coded Convolutional Spiking Neural Network,” was granted by the US Patents and Trademarks Office
• The company says the new patent protects its intellectual property rights to ensure it maintains its global competitive advantage in the field of neuromorphic artificial intelligence
• Brainchip is up 16.7 per cent to $2.17

Global technology company, BrainChip Holdings (BRN) has been granted its eighth US patent.

The patent, entitled “Event based Classification of Features in a Reconfigurable and Temporally Coded Convolutional Spiking Neural Network,” was granted by the US Patents and Trademarks Office.

A key feature of the new patent includes the protection of BrainChip’s neuromorphic processor, configured to perform convolutions on digital input data that has been converted into spikes.

The protection also extends to BrainChip’s learning function, implemented at the individual neuron level.

BrainChip Akida neural processors are configurable as both convolutional neural networks (CNN) and fully connected neurons, therefore enabling a wide range of existing AI applications used in industry to be ported to Akida neural processors.

BrainChip CTO and founder Peter van der Made said the eighth patent the company has secured since 2008 protects its intellectual property rights to ensure the company maintains its global competitive advantage in the field of neuromorphic artificial intelligence.

“As the world’s first and only commercial producer of neuromorphic artificial intelligence chips, Akida1000, we must maintain our lead over our competitors by ensuring our unique and revolutionary technology is protected and secure,” said Peter van der Made.

The company said protecting its intellectual property remains a strong focus going into the new year.

Brainchip were up 16.7 per cent to $2.17 at 10:25 am AEDT.